Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Rubén Rodríguez-Bautista"'
Autor:
Abraham Pedroza-Torres, Sandra L. Romero-Córdoba, Montserrat Justo-Garrido, Iván Salido-Guadarrama, Rubén Rodríguez-Bautista, Sarita Montaño, Rodolfo Muñiz-Mendoza, Cristian Arriaga-Canon, Verónica Fragoso-Ontiveros, Rosa María Álvarez-Gómez, Greco Hernández, Luis A. Herrera
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Dysregulated metabolism is a common feature of cancer cells and is considered a hallmark of cancer. Altered tumor-metabolism confers an adaptive advantage to cancer cells to fulfill the high energetic requirements for the maintenance of high prolifer
Externí odkaz:
https://doaj.org/article/364c41fa0dfe4c3499694261406b16a2
Autor:
Rubén Rodríguez Bautista, Alette Ortega Gómez, Alfredo Hidalgo Miranda, Alejandro Zentella Dehesa, Cynthia Villarreal-Garza, Federico Ávila-Moreno, Oscar Arrieta
Publikováno v:
Clinical Epigenetics, Vol 10, Iss 1, Pp 1-4 (2018)
Upon publication of the original article [1], the authors noticed that the Figs. 1, 2 and 3 were incorrectly given.
Externí odkaz:
https://doaj.org/article/6b529cd9a07f4c1f8493fc1ebd652ad8
Autor:
Rubén Rodríguez Bautista, Alette Ortega Gómez, Alfredo Hidalgo Miranda, Alejandro Zentella Dehesa, Cynthia Villarreal-Garza, Federico Ávila-Moreno, Oscar Arrieta
Publikováno v:
Clinical Epigenetics, Vol 10, Iss 1, Pp 1-15 (2018)
Abstract Triple-negative breast cancer (TNBC) has been clinically difficult to manage because of tumor aggressiveness, cellular and histological heterogeneity, and molecular mechanisms’ complexity. All this in turn leads us to evaluate that tumor b
Externí odkaz:
https://doaj.org/article/47777c096eae451babbe3a16efa0dcdf
Autor:
Eric Ortiz Valdez, Claudia Rangel‑Escareño, Juan Antonio Matus Santos, Rafael Vázquez Romo, Alberto Guijosa, Cynthia Villarreal‑Garza, Oscar Arrieta, Rubén Rodríguez‑Bautista, Claudia Caro‑Sánchez, Alette Ortega Gómez
Publikováno v:
Molecular and clinical oncology. 18(1)
Triple negative breast cancer (TNBC) is an aggressive type of cancer that accounts for ~23% of breast tumors in Mexico. In an attempt to understand in an improved way the behavior of TNBC, throughout the years, gene expression in these tumors has bee
Autor:
Rubén Rodríguez-Bautista, Claudia H. Caro-Sánchez, Paula Cabrera-Galeana, Gerardo J. Alanis-Funes, Everardo Gutierrez-Millán, Santiago Ávila-Ríos, Margarita Matías-Florentino, Gustavo Reyes-Terán, José Díaz-Chávez, Cynthia Villarreal-Garza, Norma Y. Hernández-Pedro, Alette Ortega-Gómez, Luis Lara-Mejía, Claudia Rangel-Escareño, Oscar Arrieta
Publikováno v:
Cancers; Volume 13; Issue 24; Pages: 6256
Cancers, Vol 13, Iss 6256, p 6256 (2021)
Cancers
Cancers, Vol 13, Iss 6256, p 6256 (2021)
Cancers
Simple Summary Triple-negative breast cancer (TNBC) is an aggressive and highly heterogeneous breast cancer subtype, both molecular and transcriptomic. Gene expression patterns identified seven TNBC subtypes; basal-like 1 (BL1), basal-like 2 (BL2), i
Autor:
Sarita Montaño, Verónica Fragoso-Ontiveros, Montserrat Justo-Garrido, Greco Hernández, Ivan Salido-Guadarrama, Rosa María Álvarez-Gómez, Abraham Pedroza-Torres, Rodolfo Muñiz-Mendoza, Cristian Arriaga-Canon, Sandra Romero-Cordoba, Rubén Rodríguez-Bautista, Luis A. Herrera
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Frontiers in Oncology
Frontiers in Oncology
Dysregulated metabolism is a common feature of cancer cells and is considered a hallmark of cancer. Altered tumor-metabolism confers an adaptive advantage to cancer cells to fulfill the high energetic requirements for the maintenance of high prolifer
Autor:
Alfredo Hidalgo Miranda, Alette Ortega Gómez, Oscar Arrieta, Alejandro Zentella Dehesa, Rubén Rodríguez Bautista, Cynthia Villarreal-Garza, Federico Ávila-Moreno
Publikováno v:
Clinical Epigenetics, Vol 10, Iss 1, Pp 1-15 (2018)
Clinical Epigenetics
Clinical Epigenetics
Triple-negative breast cancer (TNBC) has been clinically difficult to manage because of tumor aggressiveness, cellular and histological heterogeneity, and molecular mechanisms’ complexity. All this in turn leads us to evaluate that tumor biological
Autor:
Rubén Rodríguez-Bautista, Alejandro Avilés-Salas, Gerardo J. Alanis-Funes, Camilo Molina-Romero, Alette Ortega-Gómez, Claudia Rangel-Escareño, Oscar Arrieta, Alfredo Hidalgo-Miranda, Eleazar Omar Macedo-Pérez, Alejandra Lara-Garcia
Publikováno v:
Respiratory Research
Background Tobacco-smoke is the major etiological factor related to lung cancer. However, other important factor is chronic wood smoke exposure (WSE). Approximately 30 % of lung cancer patients in Mexico have a history of WSE, and present different c